Literature DB >> 25824771

MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.

Hong-Liang Liang1, Ai-Ping Hu, Sen-Lin Li, Jia-Ping Xie, Qing-Zhu Ma, Ji-Yong Liu.   

Abstract

Previous studies have shown that miR-454 plays an important role in a variety of biological processes in various human cancer cells. However, the underlying mechanisms of this microRNA in colorectal cancer (CRC) cells remain largely unknown. In the present study, we investigated the miR-454 role in CRC cell proliferation. We found that miR-454 expression is markedly upregulated in CRC tissues and CRC cells compared with the matched tumor adjacent tissues and the FHC normal colonic cell line. Ectopic expression of miR-454 promoted the proliferation and anchorage-independent growth of CRC cells, whereas inhibition of miR-454 reduced this effect. Bioinformatics analysis further revealed cylindromatosis (CYLD), a putative tumor suppressor as a potential target of miR-454. Data from luciferase reporter assays showed that miR-454 directly binds to the 3'-untranslated region (3'-UTR) of CYLD mRNA and repressed expression at both transcriptional and translational levels. In functional assays, CYLD-silenced in miR-454-in-transfected SW480 cells have positive effect to promote cell proliferation, suggesting that direct CYLD downregulation is required for miR-454-induced CRC cell proliferation. In sum, our data provide compelling evidence that miR-454 functions as an onco-miRNA, playing a crucial role in the promoting cell proliferation in CRC, and its oncogenic effect is mediated chiefly through direct suppression of CYLD expression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25824771     DOI: 10.7314/apjcp.2015.16.6.2397

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  14 in total

1.  MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD.

Authors:  Baoyou Sun; Lei Li; Wendong Ma; Shikang Wang; Chunjin Huang
Journal:  Tumour Biol       Date:  2015-12-28

2.  MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.

Authors:  Shuai Li; Yulian Ma; Xinfang Hou; Ying Liu; Ke Li; Shuning Xu; Jufeng Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer.

Authors:  Qun Li; Jia Liu; Xianying Meng; Renzhu Pang; Jie Li
Journal:  J Biol Res (Thessalon)       Date:  2017-08-03       Impact factor: 1.889

4.  Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.

Authors:  De-Ying Wang; Na Li; Yu-Lan Cui
Journal:  Cancer Res Treat       Date:  2020-03-03       Impact factor: 4.679

5.  Pioglitazone alleviates oxygen and glucose deprivation-induced injury by up-regulation of miR-454 in H9c2 cells.

Authors:  Nianzi Sun; Lin Yang; Qian Zhang; Chengwei Zou
Journal:  Iran J Basic Med Sci       Date:  2018-10       Impact factor: 2.699

6.  miR-454-3p promotes of human glioma cell growth by targeting EGR3.

Authors:  Guoliang Shen; Jian Wu; Zhaohui Mou; Danlong Chen; Li Liu; Xing Li
Journal:  Exp Ther Med       Date:  2019-09-25       Impact factor: 2.447

7.  Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.

Authors:  Zuzana Vojtechova; Ivan Sabol; Martina Salakova; Jana Smahelova; Jiri Zavadil; Lubomir Turek; Marek Grega; Jan Klozar; Bohumir Prochazka; Ruth Tachezy
Journal:  BMC Cancer       Date:  2016-07-04       Impact factor: 4.430

8.  MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma.

Authors:  Yue Fan; Li-Li Xu; Chen-Ye Shi; Wei Wei; Dan-Song Wang; Ding-Fang Cai
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

Review 9.  MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis.

Authors:  Lingshuang Lü; Xuhua Mao; Peiyi Shi; Biyu He; Kun Xu; Simin Zhang; Jianming Wang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

10.  Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5.

Authors:  Guangru Xu; Hongxing Zhu; Minghui Zhang; Jinhua Xu
Journal:  Int J Mol Med       Date:  2017-10-31       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.